Beautiful Virgin Islands

Tuesday, Jun 03, 2025

EU orders raid of AstraZeneca vaccine plant in Belgium as row over Covid jabs escalates

EU orders raid of AstraZeneca vaccine plant in Belgium as row over Covid jabs escalates

Belgian regulators carried out an inspection of AstraZeneca’s coronavirus vaccine production site near Brussels at the behest of the European Commission, amid an ongoing spat over the deployment of the company’s Covid-19 vaccine.
During the inspection ordered by the European Union’s executive branch, samples and records were taken from the Novasep factory, in the town of Seneffe, outside Brussels, to be analyzed by officials from Belgium’s Federal Agency for Medicines and Health Products (FAGG).

The inspection marks an escalation in the ongoing row between the bloc and the pharmaceutical company over Covid-19 vaccine delivery delays to member states. The FAGG confirmed on Thursday that the commission had requested an inspection of production flows.

Deliveries of the AstraZeneca Covid-19 vaccine throughout the EU are now in doubt, but the company has assured the UK government it will be capable of delivering two million doses per week to Britain, fulfilling its total order of 100 million doses. The EU is investigating whether doses manufactured in European territory have been rerouted in recent weeks to fill the UK order.

The inspection was carried out to “make sure that the delivery delay is indeed due to a production problem on the Belgian site,” France Dammel, a spokesperson for Belgium’s health ministry said, adding that it “was conducted in full transparency and objectivity.”

“Belgian experts are now examining the elements that were collected, together with experts from the Netherlands, Italy and Spain,” he said. An initial report on the findings is expected within days, with a follow-up inspection already planned in the coming weeks.

The Anglo-Swedish drugs maker announced last week that it planned to cut initial EU deliveries from 80 million to 31 million, citing reduced yields from its European manufacturing facilities. However, the EU disputes this and claims it will receive just a quarter of the vaccines agreed to between the 27-nation bloc and the pharma giant.

Stella Kyriakides, the European Commissioner for Health and Food Safety, decried the “continued lack of clarity on the delivery schedule,” following a third round of talks with the drugs manufacturer on Wednesday.

The European Medicines Agency is expected to make a decision on whether to grant approval to the AstraZeneca jab on Friday. Ahead of that decision, the German authorities have recommended that the AstraZeneca vaccine be given only to people aged between 18 and 64, amid safety and efficacy concerns about its use among older and more vulnerable demographics.
Newsletter

Related Articles

Beautiful Virgin Islands
0:00
0:00
Close
Dutch government falls as far-right leader Wilders quits coalition
Harvard Urges US to Unfreeze Funds for Public Health Research
Businessman Mauled by Lion at Luxury Namibian Lodge
Researchers Consider New Destinations Beyond the U.S.
53-Year-Old Doctor Claims Biological Age of 23
Trump Struggles to Secure Trade Deals With China and Europe
Russia to Return 6,000 Corpses Under Ukraine Prisoner Swap Deal
Microsoft Lays Off Hundreds More Amid Restructuring
Harvey Weinstein’s Publicist Embraces Notoriety
Macron and Meloni Seek Unity Despite Tensions
Trump Administration Accused of Obstructing Deportation Cases
Newark Mayor Sues Over Arrest at Immigration Facility
Center-Left Candidate Projected to Win South Korean Presidency
Trump’s Tariffs Predicted to Stall Global Economic Growth
South Korea’s President-Elect Expected to Take Softer Line on Trump and North Korea
Trump’s China Strategy Remains a Geopolitical Puzzle
Ukraine Executes Long-Range Drone Strikes on Russian Airbases
Conservative Karol Nawrocki wins Poland’s presidential election
Study Identifies Potential Radicalization Risk Among Over One Million Muslims in Germany
Good news: Annalena Baerbock Elected President of the UN General Assembly
Apple Appeals EU Law Over User Data Sharing Requirements
South Africa: "First Black Bank" Collapses after Being Looted by Owners
Poland will now withdraw from the EU migration pact after pro-Trump nationalist wins Election
"That's Disgusting, Don’t Say It Again": The Trump Joke That Made the President Boil
Trump Cancels NASA Nominee Over Democratic Donations
Paris Saint-Germain's Greatest Triumph Is Football’s Lowest Point
OnlyFans for Sale: From Lockdown Lifeline to Eight-Billion-Dollar Empire
Mayor’s Security Officer Implicated | Shocking New Details Emerge in NYC Kidnapping Case
Hegseth Warns of Potential Chinese Military Action Against Taiwan
OPEC+ Agrees to Increase Oil Output for Third Consecutive Month
Jamie Dimon Warns U.S. Bond Market Faces Pressure from Rising Debt
Turkey Detains Istanbul Officials Amid Anti-Corruption Crackdown
Taylor Swift Gains Ownership of Her First Six Albums
Bangkok Ranked World's Top City for Remote Work in 2025
Satirical Sketch Sparks Political Spouse Feud in South Korea
Indonesia Quarry Collapse Leaves Multiple Dead and Missing
South Korean Election Video Pulled Amid Misogyny Outcry
Asian Economies Shift Away from US Dollar Amid Trade Tensions
Netflix Investigates Allegations of On-Set Mistreatment in K-Drama Production
US Defence Chief Reaffirms Strong Ties with Singapore Amid Regional Tensions
Vietnam Faces Strategic Dilemma Over China's Mekong River Projects
Malaysia's First AI Preacher Sparks Debate on Islamic Principles
White House Press Secretary Criticizes Harvard Funding, Advocates for Vocational Training
France to Implement Nationwide Smoking Ban in Outdoor Spaces Frequented by Children
Meta and Anduril Collaborate on AI-Driven Military Augmented Reality Systems
Russia's Fossil Fuel Revenues Approach €900 Billion Since Ukraine Invasion
U.S. Justice Department Reduces American Bar Association's Role in Judicial Nominations
U.S. Department of Energy Unveils 'Doudna' Supercomputer to Advance AI Research
U.S. SEC Dismisses Lawsuit Against Binance Amid Regulatory Shift
Alcohol Industry Faces Increased Scrutiny Amid Health Concerns
×